← Back to all trials
Completed
NCT07875543
Comparison of the Therapeutic Effects of Lyophilized Platelet-rich Plasma Lysate and Dextrose Prolotherapy in Knee Osteoarthritis
Conditions: Knee Osteoarthritis, Platelet-rich Plasma (PRP)
Sex: All
Ages: 20 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 39
Sponsor: Taichung Veterans General Hospital
Location: Taichung Veterans General Hospital Taichung
Summary
The goal of this clinical trial is to compare the therapeutic effects of lyophilized platelet-rich plasma lysate and dextrose prolotherapy in patients with knee osteoarthritis (OA). The main questions it aims to answer are:
* Does lyophilized platelet-rich plasma lysate improve pain, physical function, and muscle strength in patients with knee osteoarthritis?
* Is lyophilized platelet-rich plasma lysate more effective than dextrose prolotherapy in improving clinical outcomes in patients with knee osteoarthritis?
Researchers will compare patients receiving lyophilized platelet-rich plasma lysate with those receiving dextrose prolotherapy to evaluate differences in treatment effectiveness.
Participants will:
* Receive intra-articular injections of either lyophilized platelet-rich plasma lysate or dextrose prolotherapy.
* Undergo clinical assessments before and after treatment, including the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) to evaluate pain, stiffness, and physical function.
* Undergo knee X-ray examinations to assess osteoarthritis severity using the Kellgren-Lawrence (KL) grading system.
* Undergo isokinetic muscle strength testing using a Biodex dynamometer to evaluate knee muscle strength.
Eligibility Criteria
Inclusion Criteria:
* Patients with radiographically confirmed knee osteoarthritis of Kellgren-Lawrence grade III or lower.
Patients older than 20 years of age.
Patients who are willing to provide written informed consent.
Exclusion Criteria:
* Platelet dysfunction.
Thrombocytopenia.
Hypofibrinogenemia.
Hemodynamic instability.
Sepsis.
Acute or chronic infectious diseases.
History of chronic liver disease.
Current anticoagulant therapy.
Long-term or excessive use of aspirin or vitamin E.
History of HIV infection, syphilis, or other legally notifiable infectious diseases.
Cognitive impairment that prevents compliance with study procedures or medical instructions.
Source: ClinicalTrials.gov (NCT07875543). StuddyBuddy aggregates publicly available trial information.